Mesoblast (MESO) Return on Capital Employed [ROCE] (2016 - 2023)
Mesoblast (MESO) recorded Return on Capital Employed [ROCE] of 37.04% in the year ended Jun 30, 2026, up 23.23 percentage points from 13.81% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Return on Capital Employed [ROCE] (2016 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's Return on Capital Employed [ROCE] history includes 12 years.
- Annual Return on Capital Employed [ROCE] has a five-year change of +54.15 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 is the highest annual Return on Capital Employed [ROCE] in data going back to the year ended Jun 30, 2015.
- Per Business Quant data, MESO's Return on Capital Employed [ROCE] was 13.81% in the year ended Jun 30, 2025 (+1.96 pp), 11.84% in the year ended Jun 30, 2024 (-2.23 pp), 14.07% in the year ended Jun 30, 2023 (+30.77 pp) and -16.70% in the year ended Jun 30, 2022 (+0.41 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Mesoblast | 1.81 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -10.02% |
| Mar 31, 2023 | -10.17% |
| Dec 31, 2022 | -10.51% |
| Sep 30, 2022 | -10.83% |
| Jun 30, 2022 | -11.90% |
| Mar 31, 2022 | -12.47% |
| Dec 31, 2021 | -13.00% |
| Sep 30, 2021 | -13.45% |
| Jun 30, 2021 | -13.45% |
| Mar 31, 2021 | -15.55% |
| Dec 31, 2020 | -14.54% |
| Sep 30, 2020 | -14.19% |
| Jun 30, 2020 | -11.92% |
| Mar 31, 2020 | -10.09% |
| Dec 31, 2019 | -11.97% |
| Sep 30, 2019 | -12.52% |
| Jun 30, 2019 | -13.99% |
| Mar 31, 2019 | -13.65% |
| Dec 31, 2018 | -13.31% |
| Sep 30, 2018 | -10.82% |
API Access
Mesoblast Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();